Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation

SUNNYVALE, California, July 14, 2011 -

Molecular Devices, LLC, a leader in bioanalytical systems for
drug discovery & development, life science research, and
bioassay/test development, today announced that the American
Association for Laboratory Accreditation (A2LA) has accredited the
Laboratory Quality System under ISO/IEC 17025 for validation plate
calibration and re-calibration processes.

(Logo: href="photos.prnewswire.com/prnh/20100406/SF82092LOGO">photos.prnewswire.com/prnh/20100406/SF82092LOGO)

Molecular Devices is one of the first companies servicing the
pharmaceutical industry to achieve ISO/IEC 17025 accreditation for
validation plate calibration and re-calibration processes for
microplate readers. The ISO/IEC 17025 accreditation process is very
rigorous, with quality assurance requirements designed to ensure
that all calibrations carried out reflect an accurate reading
within a defined level of uncertainty. All calibration procedures
performed at Molecular Devices comply with the ISO/IEC 17025
criteria; namely, they are performed by competent technicians in a
controlled environment, using reference instruments or materials in
which the end user can operate an administrative quality system
similar to ISO 9001.

Mikey Kindler, Director of Marketing, BioResearch Products,
commented: “With any calibration measurement, having confidence in
the results is critically important.  We are proud to have the
ISO/IEC 17025 accreditation for validation plate calibration to
help give our customers that confidence.”  The validation
plate calibration and re-calibration processes are an integral part
of Molecular Devices’ offering.  The quality control and
validation tools are used to validate instrument and software
performance to ensure quality cell lines for assays and to help
customers comply with Good Laboratory and Manufacturing Practices
(GxP). Molecular Devices was the first to support regulatory
compliance for microplate readers, and one of the key products to
empower customers in regulated environments is the IQ/OQ/PQ
Guidelines to aid system owners in qualifying their SpectraMax®
line of microplate readers and liquid handling systems.

The validation plates are the most comprehensive test tools on
the market for confirming the industry-leading performance in
absorbance, fluorescence, and luminescence.

All of the relevant instrument validation protocols are handled
by protocols within award-winning SoftMax Pro software. SoftMax
Pro® GxP Compliance Software extends Molecular Devices’ leading
data acquisition and analysis solution into regulated laboratories
working under GMP, GLP, 21 CFR Part 11, and other similar
guidelines for secure electronic records.

To find out more about our ISO/IEC 17025 accreditation to our
validation plate calibration and re-calibration processes and our
validation tools please visit our website
www.moleculardevices.com.

About Molecular Devices: At Molecular Devices we have one
focus-our customers. When you become our customer, your needs drive
our actions and your success is our concern. Our instruments offer
a full spectrum of detection technologies and meet all throughput
and content needs. Our goal is to deliver highly relevant
bioanalytical products to detect biology, decode data, and drive
discovery.

Global Sales & Support Offices:  N America:
1-800-635-5577, Brazil: +55-11-3616-6607; UK:
+44-118-944-8000; Germany: +49-89/96-05-88-0; China:
+86-10-6410-8669 (Beijing), +86-21-33721088 (Shanghai);
Japan: +81-6-6399-8211 (Osaka), +81-3-5282-5261 (Tokyo);
S Korea: +82-2-3471-9531

All products are FOR RESEARCH USE ONLY. Not for Use in
Diagnostic Procedures.

All trademarks are the property of Molecular Devices, Inc.

James Ford, BA (Hons) DipM MCIM, Marketing and Communications Manager, Molecular Devices, Inc., +44-(0)118-944-4693, james.ford at moldev.com